South Wales, Dec. 12 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "LOHYPTO" on Sept. 29. The details about the trademark application no. UK00004270852 published in the journal no. 2025/050 (Dec. 12).
With HGF Limited as representative, Mineralys Therapeutics, Inc. filed the trademark application for the below mentioned good(s)/service(s).
Class 5 : Pharmaceutical preparations for the prevention and treatment of hypertension, sleep apnea, chronic kidney disease, heart failure, primary aldosteronism, myocardial infarction, coronary artery disease, blood vessel wall thickening, renal fibrosis, nephropathy, and vascular dementia.
The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004270852
Disclaimer: Curated by HT Syndication.
